Issue Highlights

Product Note

LAURUS LABS LIMITED
Public Issue of Equity Shares

Issue Highlights

Product Note

Issue opens: / Tuesday, December 06, 2016
Issue closes: / Thursday, December 08, 2016
Price Band:
Rs. 426 – Rs. 428
Bid Lot:
35 Equity Shares and in Multiples thereafter
Face Value: / Rs. 10/- per share
Listing: / BSE & NSE
Registrar: / Karvy Computershare Private Limited
Payment: / Compulsorily ASBA Mode
Discount: / Rs.40/- to Eligible Employees:

Business Overview

Laurus Labs Limited are a leading research and development (“R&D”) driven pharmaceutical company in India, with a leadership position in generic active pharmaceutical ingredients (“APIs”) for select, high-growth therapeutic areas of anti-retrovirals (“ARVs”) and Hepatitis C. (Source: Frost & Sullivan Report) The Company also manufactures APIs in oncology and other therapeutic areas.

The Company’s strategic and early investments in R&D and manufacturing infrastructure has enabled them to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing “donor-funded access-to-medicines markets” of Sub-Saharan Africa, South-East Asia and Latin America.

Promoters Of The Company

Dr. Satyanarayana Chava, Naga Rani Chava, Dr. Raju Srihari Kalidindi, Ravi Kumar V V And Dr. Lakshmana Rao C V

Object of the Issue

The proceeds of the Offer for Sale shall be received by the Selling Shareholders, and the Company will not receive any proceeds from the Offer for Sale.

Peer Group Company

Disclaimer: for more details please refer RHP

Divis Laboratories Limited Aurobindo Pharma Limited



Offer Size: / Fresh Issues: / Rs. 300 Crs.
Offer for Sale: / 24,107,440 Equity Shares
Employee Portion: Rs.12.5 Crs.
Net Offer Break up:
Category / Allocation / Issue Size ( Rs. in Crs)
Lower Band / Upper Band
QIB / 50% / 657.23 / 659.64
NIB / 15% / 197.17 / 197.89
Retail / 35% / 460.06 / 461.75
Total Offer / 100% / 1314.47 / 1319.29
Summary Statement of Profit and Losses, as restated
(Rs. In Million)
Particulars / Six Months ended / For the year ended
September 30, 2016 / March 31, 2016
Total Income / 9,417.89 / 17,913.65
Total Expenditure / 7,330.01 / 14,115.90
Profit Before Tax / 1,023.45 / 1,675.62
Profit after Tax / 751.02 / 1,326.51
E.P.S.(Rs.) Basic / *9.60 / 20.86
E.P.S.(Rs.) Diluted / *7.59 / 13.48
RONW (%) / *8.08 / 15.57
*Not annualised

Retail Payment Chart

Compulsory ASBA mode. No Cheque will be accepted.

Cut Off Price Rs. 428/- Per Share

No. of Shares / Amount / No. of Shares / Amount
35 / 14980 / 280 / 119840
70 / 29960 / 315 / 134820
105 / 44940 / 350 / 149800
140 / 59920 / 385 / 164780
175 / 74900 / 420 / 179760
210 / 89880 / 455 / 194740
245 / 104860

An indicative timetable post issues closing

Finalisation of Basis of Allotment with the / On or about
Designated Stock Exchange / December 14, 2016
Initiation of refunds (if any, for Anchor / On or about
Investors) / unblocking of funds from ASBA
December 15, 2016
Account
Credit of Equity Shares to demat accounts / On or about
of Allottees / December 16, 2016
Commencement of trading of the Equity / On or about
Shares on the Stock Exchanges / December 19, 2016

Product Note